- Home
- NVCT vs CHEC Comparison
NVCT vs CHEC Comparison
Compare NVCT & CHEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$7.64
Company Overview
Basic Information| Metric | NVCT | CHEC |
|---|---|---|
| Founded | 2020 | 2024 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.0M | 171.7M |
| IPO Year | 2022 | 2025 |
Fundamental Metrics
Financial Performance| Metric | NVCT | CHEC |
|---|---|---|
| Price | $7.64 | $9.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $15.33 | N/A |
| AVG Volume (30 Days) | ★ 87.9K | 6.5K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.03 | $9.91 |
| 52 Week High | $11.52 | $10.56 |
Technical Indicators
Market Signals| Indicator | NVCT | CHEC |
|---|---|---|
| Relative Strength Index (RSI) | 57.08 | N/A |
| Support Level | $7.57 | N/A |
| Resistance Level | $7.91 | N/A |
| Average True Range (ATR) | 0.38 | 0.00 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 33.76 | 0.00 |
Price Performance
Historical Comparison NVCT
CHEC
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About CHEC Chenghe Acquisition III Co. Class A Ordinary Share
Chenghe Acquisition III Co is blank check company.